BEAM (BEAM) Stock Price & Analysis
BEAM (BEAM) rose 0.00% to USD 25.1 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
BEAM last closed at USD 25.1; the session ranged USD 24.85–26.41 on volume of 1,773,779 shares. Market capitalization is —, with a 52-week range of USD 15.6–38.26 (NMS). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 25.1 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 25.1 |
| Open | USD 25.1 |
| Day Range | USD 24.85 – 26.41 |
| 52-Week Range | USD 15.6 – 38.26 |
| Volume | 1,773,779 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BEAM)
Nexqual's technical model rates BEAM "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.3 (neutral) |
| vs SMA50 | Below (USD 30.99) |
| MACD | -1.75 (negative) |
From BEAM's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | USD 10.73 | ▼ 3.59% |
| EDIT | Editas Medicine, Inc. | USD 2.6 | ▼ 6.47% |
| TWST | Twist Bioscience Corporation | USD 90.27 | ▼ 4.18% |
| CRSP | CRISPR Therapeutics AG | USD 46.54 | ▼ 1.48% |
| FATE | Fate Therapeutics, Inc. | USD 2.41 | ▼ 6.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.